An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone with a new shoulder tendon tear — a 27-year-old nurse who used to be very active — posted that they’ve never used peptides and are thinking about trying BPC‑157 and TB‑500 to help the 10 mm supraspinatus (rotator cuff) tear that hasn’t healed after three months. That’s the basic news: a person with a real injury is considering experimental peptide treatments and asking for help or guidance. BPC‑157 and TB‑500 are short chains of amino acids (peptides). They’re not household drugs like ibuprofen; they’re lab-made fragments of proteins that some people say can help tissue heal. BPC‑157 was originally studied as a gut-related peptide and is sometimes described as promoting blood vessel growth and tissue repair in animals. TB‑500 is a synthetic piece of the naturally occurring protein thymosin beta‑4 and is claimed to help cell movement and wound healing. Neither is an approved, widely prescribed treatment for tendon tears in humans. What the research actually shows is limited and mostly in animals or tiny human reports. In rats and mice, studies have suggested these peptides can speed healing of tendons, muscles, and gut tissue. But animal results don’t always translate to people. There are a few small, low‑quality human reports or anecdotal accounts, but no large, controlled clinical trials proving they reliably repair tendon tears or are safe long term. In short: promising in labs and stories, not proven in rigorous human studies for this specific kind of shoulder tear. Why it matters is practical: a 10 mm supraspinatus tear that hasn’t improved after three months is a real problem for quality of life and work, especially for someone who needs their arm and used to be very active. People in that situation understandably want options beyond rest, physical therapy, injections, or surgery. If a peptide truly helped tendons heal, it could shorten downtime and avoid surgery. That potential is why people are experimenting with these products despite the lack of solid human evidence. There are important caveats and risks. These peptides are generally sold as research chemicals or compounded products, so dosing, purity, and sterility are inconsistent. Possible side effects are not well documented; unknown long‑term effects are a real concern. Using them instead of medically recommended care could delay proven treatments. Also, if surgery is indicated, trying unproven treatments first might affect surgical options. Legally and medically, they’re not approved therapies for tendon tears, so discuss any plan with an orthopedic surgeon or sports medicine specialist, and consider getting imaging and a second opinion before starting anything experimental. Bottom line: BPC‑157 and TB‑500 are experimental options with some encouraging animal data and lots of anecdote, but limited reliable human evidence and uncertain safety — talk to a specialist before trying them.
Source: r/Peptides